Use of the IgG degrader imlifidase for a poorly desensitized patient undergoing haematopoietic stem cell transplantation with donor-specific antibodies. uri icon

Overview

publication date

  • February 6, 2025

Identity

Scopus Document Identifier

  • 85217021083

Digital Object Identifier (DOI)

  • 10.1111/bjh.20004

PubMed ID

  • 39915967

Additional Document Info

volume

  • 206

issue

  • 3